l-carnitine as a supplement 250 mg JYM L-Carnitine L-Tartrate

Knockdown of MFRN1 enhances HMOX2 ubiquitination by MITOL

Existing studies are largely confined to small IVF cohorts or mixed POI/PCOS populations, often characterized by inconsistent dosing regimens, variable bioavailability, short follow-up periods, and the use of surrogate endpoints (e.g., AMH levels) rather than clinically meaningful outcomes such as live birth rates

Cell 148(12):322334

Escitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects

doi: 10.1038/s41598-023-37152-7 159 ShahriariMKesharwaniPJohnstonTPSahebkarA